TB-500 10mg

$89.99

Designed for researchers studying tissue repair, mobility support, inflammation response, and recovery pathways.

Product Overview

TB-500 is the synthetic version of Thymosin Beta-4, a peptide naturally present in most human and animal cells. It is widely studied for its role in tissue repair, cell migration, cytoskeletal support, and regenerative signaling. TB-500 contains the actin binding region of the full Thymosin Beta-4 molecule, giving it key bioactive properties while offering improved stability for laboratory use. Research often focuses on its effects in soft tissue repair, muscle recovery, angiogenesis, and anti inflammatory pathways.

Applications in Research

  • Soft tissue and dermal healing models
  • Angiogenesis and cell migration studies
  • Muscle regeneration and recovery investigations
  • Cardiac repair and anti inflammatory research pathways

Storage and Handling

Store the lyophilized peptide at minus 20°C in a dry and dark environment. Reconstitute with sterile bacteriostatic water. After reconstitution, keep refrigerated and use within standard laboratory timelines. Avoid repeated freeze and thaw cycles.

RESEARCH USE ONLY – LEGAL DISCLAIMER

All Nivo Labs products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind.

By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose.

Use of these materials is entirely at your own risk. Nivo Labs assume no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.